Current Treatment of 1L Hodgkin Lymphoma

University of Miami Sylvester Comprehensive Cancer Center

C. Moskowitz

ESMO 2024 Summary: Updates in the Treatment of MCL

2024 ESMO Annual Meeting Insights Hub

G. Hess

Overview of CNS Cancers

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

V. Venur

Standards of Care and Future Directions in FL

Martin Dreyling

Treatment Updates and Management of Hodgkin Lymphoma

Integrity CE

A. Niu, D. Wallace, M. Cortese

Treatment Updates and Management of Non-Hodgkin Lymphomas

Integrity CE

D. Wallace, M. Cortese

CAR T-Cell Therapy in Autoimmune Disorders

Vanderbilt University Medical Center (VUMC)

O. Oluwole

Bispecifics for LBCL: Guidance for Management of Toxicities in the C…

UChicago Medicine

J. Crombie

Hematopathology Tumor Board: Case Studies and Diagnostic Challenges …

UChicago Medicine

G. Venkataraman, A. Perry, K. Cahill, A. Akmatbekov, L. Wu

Cutaneous Lymphoma 101: Overview on Diagnosis, Staging and Prognosis

Basem William

Current Management of Peripheral T-Cell Lymphoma

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

C. Poh

MZL: Current Management and Emerging Therapeutics

University of Miami Sylvester Comprehensive Cancer Center

I. Lossos

DLBCL: Principles of Diagnosis, Prognosis and Staging

University of Colorado Division of Hematology

C. Pearson

EHA 2024 Insights: Intrathecal Rituximab + Dex for Refractory Sanctu…

Insights from 2024 EHA Annual Meeting

M. Salamoon

Practical Aspects of Bispecifics in NHL: Supportive Care and Minimiz…

UChicago Medicine

K. Kelly

How to Assess and Treat Elderly Patients With DLBCL

UChicago Medicine

S. Luminari

Caring for Patients With Lymphoma: Using Guidelines to Improve Quali…

Yale Cancer Center

S. Huntington, E. Winer

Update on Cellular Therapy in Lymphoma

Total Health

B. Randolph

DLBCL: How Do We Choose Initial Therapy?

University of Colorado Division of Hematology

C. Pearson